Article Details
Retrieved on: 2024-05-30 05:31:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ikena Oncology, Inc. IKNA+20.3%. + Free Alerts. gained 22.5% to $1.63 after the company announced it will discontinue development of IK-930 and ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here